Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Female population were 73.11% and 64.84% respectively in low FIB4 and high FIB4 group.The prevalence of at-risk NASH is 45.05% in high FIB4 group and 18.82% in low FIB4 group
Orders over $200 include free shipping
(p=0.837)
Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M
As the FDA finalizes this pathway, we intend to be ready to bring these therapies to patients at the highest medical and clinical standards similar to our IRB clinical trial we used with our athletes
US$ 24.49
US$ 29.40
US$ 22.35
US$ 20.47
US$ 22.31
US$ 22.00
US$ 28.38
